Orthogen AG
Records under this name other than the patents Orthogen AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 7 of 7 · Back to Orthogen AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,575,780 | Method for Manufacturing Particles for Use in Forming a Resorbable Implant for Stimulating Bone Growth Lapsed on the fee record Ended Aug 18, 2021 · Medium confidence | Lapsed on the fee record | Ended Aug 18, 2021 | Medium confidence |
| US 6,713,246 | Method of producing interleukin-1 receptor antagonist in a syringe filled with blood Term ended Term ended Aug 1, 2021 · From the USPTO record | Term ended | Term ended Aug 1, 2021 | From the USPTO record |
| US 6,759,188 | Method for producing interleukin 1 receptor antagonists, a therapeutic activity protein, from body fluids Term ended Term ended Aug 1, 2021 · From the USPTO record | Term ended | Term ended Aug 1, 2021 | From the USPTO record |
| US 7,863,352 | Polymer containing calcium sulfate particles for bone augmentation Term ended Ended no later than Aug 1, 2021 · From the USPTO record | Term ended | Ended no later than Aug 1, 2021 | From the USPTO record |
| US 7,488,761 | Polymer Containing Calcium Sulfate Particles for Bone Augmentation Lapsed on the fee record Ended Feb 10, 2021 · Medium confidence | Lapsed on the fee record | Ended Feb 10, 2021 | Medium confidence |
| US 7,465,293 | Syringe for inducing therapeutically-effective proteins Lapsed on the fee record Ended Dec 16, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 16, 2020 | From the USPTO record |
| US 6,623,472 | Method for inducing therapeutically-effective proteins Term ended Term ended Jul 6, 2020 · From the USPTO record | Term ended | Term ended Jul 6, 2020 | From the USPTO record |